Most cells in the body send out little messengers called extracellular vesicles that carry proteins, lipids, and other ...

When diagnosing lung metastases and second primary lung cancer in patients with head and neck cancer, low-dose CT leads to better sensitivity than chest x-ray but does not lead to improved overall ...

Cancer Discovery publishes high-impact articles featuring major advances in research and clinical trials. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic to ...

The Food and Drug Administration (FDA) has approved Imfinzi (durvalumab) for adults with limited-stage small cell lung cancer ...

To perform the test, press your index fingers together and look for a small, diamond-shaped gap of light between them.

Metastatic lung cancer can spread to any structure or organ in the body, including the brain, liver, lymph nodes, and adrenal glands. It is also known as stage 4 non-small cell lung cancer (NSCLC).

A new laser is helping doctors detect lung cancer earlier than conventional techniques thanks to an innovative blue light. The cutting-edge technology means that the disease can be caught in its ...

Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular ...

This may affect a small or large area of the lung. Research from 2018 notes that atelectasis may be the first sign of lung cancer. Researchers also state that atelectasis is present in 30 to ⁠35 ...

Non-small cell lung cancer that has metastasized may cause different symptoms depending on where it has spread. Treatment can help reduce symptoms and prolong life. Non-small cell lung cancer ...

A recent study has shown that analysis of ctDNA methylation can aid the early diagnosis of non-small cell lung cancer (NSCLC). This study, published in the Genes and Diseases journal by ...

Oct. 9, 2024 — Researchers have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations in the STK11 and/or KEAP1 tumor suppressor ...